Getting people with Canavan disease ready for gene therapy
Project 4: an observational study in parallel to a gene therapy trial in Canavan
This project builds tools using genetics, biomarkers, and clinical data to help identify which people with Canavan disease may be best matched to upcoming gene therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11172782 on NIH RePORTER |
What this research studies
From your point of view, the team will gather medical records, genetic test results, and biomarker information from people with Canavan disease, including those seen alongside an ongoing gene therapy effort. They will create two complementary ways to predict disease subtype and likely course: a staged clinical risk approach and a machine-learning model designed for very small groups (~40 people). The models will be tested and compared across independent patient groups to see which gives the most reliable predictions. The work is meant to help guide fairer, safer trial design and make it easier to match patients to the right treatments.
Who could benefit from this research
Good fit: Ideal candidates are people with a confirmed or suspected diagnosis of Canavan disease — including infants, children, or young adults with compatible genetic testing or clinical features.
Not a fit: People who do not have Canavan disease or who have unrelated neurological conditions are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could help match Canavan patients to appropriate gene therapy trials sooner and improve trial safety and outcomes.
How similar studies have performed: Gene therapy using AAV9 for Canavan and related leukodystrophies has reached clinical trials, but using machine-learning risk stratification in ultrasmall cohorts remains relatively novel and less-tested.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Eichler, Florian S — Children's Hosp of Philadelphia
- Study coordinator: Eichler, Florian S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.